Home › US experts review heart attack risk of diabetes drug
 

Keywords :   


US experts review heart attack risk of diabetes drug

2013-06-09 08:24:16| Biotech - Topix.net

GlaxoSmithKline's controversial diabetes drug Avandia, restricted in the US and banned in Europe over concerns it raises heart attack risk, is getting a second look this week by US medical experts.

Tags: review heart risk drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »